Literature DB >> 9788466

Thrombotic thrombocytopenic purpura and simvastatin.

L J McCarthy, P Porcu, C A Fausel, C J Sweeney, C F Danielson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9788466     DOI： 10.1016/S0140-6736(05)70492-X

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  Drug-induced thrombotic microangiopathy: incidence, prevention and management.

Authors:  R Pisoni; P Ruggenenti; G Remuzzi
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

2.  A potential event-competition bias in safety signal detection: results from a spontaneous reporting research database in France.

Authors:  Francesco Salvo; Florent Leborgne; Frantz Thiessard; Nicholas Moore; Bernard Bégaud; Antoine Pariente
Journal:  Drug Saf       Date:  2013-07       Impact factor: 5.606

Review 3.  Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism.

Authors:  Beatrice A Golomb; Marcella A Evans
Journal:  Am J Cardiovasc Drugs       Date:  2008       Impact factor: 3.571

4.  Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel.

Authors:  Maciej Banach; Manfredi Rizzo; Peter P Toth; Michel Farnier; Michael H Davidson; Khalid Al-Rasadi; Wilbert S Aronow; Vasilis Athyros; Dragan M Djuric; Marat V Ezhov; Robert S Greenfield; G Kees Hovingh; Karam Kostner; Corina Serban; Daniel Lighezan; Zlatko Fras; Patrick M Moriarty; Paul Muntner; Assen Goudev; Richard Ceska; Stephen J Nicholls; Marlena Broncel; Dragana Nikolic; Daniel Pella; Raman Puri; Jacek Rysz; Nathan D Wong; Laszlo Bajnok; Steven R Jones; Kausik K Ray; Dimitri P Mikhailidis
Journal:  Arch Med Sci       Date:  2015-03-14       Impact factor: 3.318

5.  Clopidogrel-induced thrombotic thrombocytopenic purpura-hemolytic uremic syndrome after coronary artery stenting.

Authors:  Shawn M Manor; Gregory S Guillory; Suresh P Jain
Journal:  Pharmacotherapy       Date:  2004-05       Impact factor: 4.705
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.